US 11771743
Methods for preventing or treating allergy by administering an IL-4R antagonist
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11771743 (Methods for preventing or treating allergy by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K38/1774, A61K39/00